An experimental Alzheimer's drug lowered tau protein and showed early signs of slowing decline in a study of about 400 people. Larger trials still need to confirm the benefit, but it points to a new treatment path beyond amyloid.
Read more: https://apnews.com/article/d58728ee8f7d9dfd9ec8de416cddd75d
@goodnews@fedigroups.social
#GoodNews #Alzheimers #MedicalResearch #Dementia #HealthScience #ClinicalTrials
